Arjo
Arjob is a company that specializes in providing healthcare products and solutions, with a strong focus on patient handling equipment and related services. The company has demonstrated solid growth, particularly in the US and Canadian markets, driven by high demand for its innovative products like the Maxi Move 5 patient lifts. Arjob is committed to enhancing the quality of care for patients and improving operational efficiency for healthcare providers. The company is actively expanding its product segments and investing in research and development to meet changing customer needs.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueIncludes products like Maxi Move 5 for safe patient transfer.
Installation and maintenance of ceiling lifts for patient mobility.
Supply of beds designed for medical and care facilities.
Products for emergency and long-term patient care.
Rental and maintenance services for healthcare equipment.
Customers
Arjob's primary customers include public sector healthcare entities and private healthcare providers. The company serves a diverse range of clients, from hospitals and long-term care facilities to emergency care providers. A significant portion of revenue comes from sales to public sector entities, which are influenced by healthcare reimbursement systems. Arjob's products are often funded or subsidized by insurance companies in markets like the US, where reimbursement approval is crucial for sales success. The company focuses on highlighting the clinical and financial benefits of its solutions to reduce dependency on public funding.
Buys equipment for hospitals and care facilities, influenced by reimbursement systems.
Purchase equipment to enhance patient care and operational efficiency.
Fund products under reimbursement systems, crucial for sales in markets like the US.
Strategy
Arjob's strategic priorities include enhancing cost efficiency and expanding its product offerings to meet changing customer needs. The company is focused on maintaining high demand for its products, particularly in North America, and leveraging growth opportunities in emerging markets. Arjob is also committed to improving its gross margin through favorable geographical mix effects and price adjustments. The company is actively investing in research and development to drive innovation and strengthen its competitive position in the healthcare industry.
To improve profitability and offset higher costs.
To meet changing customer needs and drive growth.
To capture new market opportunities and increase revenue.
Geography
Arjob has a strong geographic presence in North America, with the US and Canada being key growth drivers. The company also operates in major European markets such as Germany, the Netherlands, and France, although there is some uncertainty regarding healthcare financing in certain regions. Arjob's strategic focus includes expanding its market share in emerging markets like India, which has become one of its top-ten largest markets. The company's operations are influenced by regional healthcare policies and reimbursement systems, which impact sales and profitability.
Risks
Arjob faces several business and financial risks, including dependency on healthcare reimbursement systems and potential changes in public funding policies. The company is exposed to currency fluctuations and tariffs, which can impact profitability. Regulatory compliance is crucial, as the healthcare market is highly regulated, and any non-compliance could affect operations. Arjob also faces risks related to supply chain disruptions and sustainability concerns, which could impact production and delivery. The company actively manages these risks through strategic initiatives and continuous monitoring.
- Healthcare Reimbursement SystemsImpact: CriticalLikelihood: Low
Changes in policies could affect sales and funding.
- Currency FluctuationsImpact: HighLikelihood: Low
Impacts profitability due to exchange rate changes.
- Regulatory ComplianceImpact: HighLikelihood: Low
Non-compliance could affect operations and product approvals.
- Supply Chain DisruptionsImpact: MediumLikelihood: Medium
Could lead to higher costs and delivery delays.
Accounting
Judgemental itemsTiming affects financial results in reimbursement-dependent markets.
Fluctuations impact profitability and require hedging.
Affects valuations of financial assets and liabilities.
Similar listed companies
Publicly listed companies with a comparable business focus.
Asker Healthcare Group
ASKER · Health Care
Asker Healthcare Group is a prominent European provider of medical products and solutions, focusing on improving patient outcomes and reducing healthcare costs.
Maximus, Inc
MMS · Services-Business Services, NEC
MAXIMUS is a U.S.-based government services contractor that designs and operates tech-enabled programs for federal, state, local, and international public agencies.
Masimo Corp
Electromedical & Electrotherapeutic Apparatus
Masimo Corp develops and markets noninvasive patient monitoring technologies, hospital automation and connectivity solutions, and remote monitoring devices for healthcare settings.
AtriCure, Inc.
ATRC · Surgical & Medical Instruments & Apparatus
AtriCure designs and sells surgical devices used by cardiac surgeons and electrophysiologists to treat atrial fibrillation, manage the left atrial appendage, and reduce post-operative pain.
Health Catalyst, Inc.
HCAT · Services-Computer Programming, Data Processing, Etc.
Health Catalyst builds cloud-based data and analytics software for healthcare organizations, combining a data platform, analytics applications, and implementation expertise.
Hyperfine, Inc.
HYPR · Electromedical & Electrotherapeutic Apparatus
Last updated: 24/09/2026